Passage Bio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-80.5M | $-80.5M | — | $14.6M |
| FY2021 | $-126.9M | $-126.9M | — | $32.7M |
| FY2022 | $-118.2M | $-118.2M | — | $19.0M |
| FY2023 | $-78.3M | $-78.3M | — | $10.9M |
| FY2024 | $-48.0M | $-48.0M | $34.0K | $5.8M |
| FY2025 | $-31.5M | $-31.5M | — | $3.0M |